12:00 AM
 | 
Aug 13, 2012
 |  BC Week In Review  |  Company News  |  Other News

Teva, Krka d.d., Lupin, Mylan, Servier, Alliance Healthcare (Distribution) Ltd. cardiovascular news

The European Commission sent a statement of objections to Servier and the generic competitors regarding an investigation into suspected violations of EU antitrust laws relating to Servier's cardiovascular drug Coversyl perindopril. The EC alleged that Servier paid Alliance (formerly Unichem Ltd.), Mylan,...

Read the full 197 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >